ArticleAnnals of surgical oncology2026

Assessing the Evidence for Neoadjuvant Chemotherapy in Patients with Resectable Pancreatic Adenocarcinoma Using the Robustness of Inference to Replacement.

Benjamin A Y Cher et al.PubMed ↗Publisher ↗

No numbers read from the abstract.